Invitation to Late-stage pipeline event Tuesday, 1 October 2013

The Roche Investor Relations team would like to invite you to a Late-stage pipeline event that will take place in London on 1 October 2013 starting at 2.30pm local time. The event will provide an opportunity to discuss clinical data and development plans for key late-stage compounds in the Roche development pipeline, including lampalizumab (anti-factor D) in dry AMD, etrolizumab in ulcerative colitis and selected oncology compounds.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news